The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Coronavirus infections and immune responses

(2020) Geng Li et al.   JOURNAL OF MEDICAL VIROLOGY

A novel coronavirus outbreak of global health concern

(2020) Chen Wang et al.   LANCET

Covid-19: preparedness, decentralisation, and the hunt for patient zero

(2020) Fabrizio Carinci   BMJ-British Medical Journal

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

(2020) Jasper Fuk-Woo Chan et al.   Emerging Microbes & Infections

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

(2020)   Nature Microbiology

Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China

(2020) Sheng-Qun Deng et al.   Journal of Clinical Medicine

COVID-19 pandemic, coronaviruses, and diabetes mellitus

(2020) Ranganath Muniyappa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Methyl-β-cyclodextrin inhibits EV-D68 virus entry by perturbing the accumulation of virus particles and ICAM-5 in lipid rafts

(2020) Yunhe Jiang et al.   ANTIVIRAL RESEARCH

Progress and Concept for COVID‐19 Vaccine Development

(2020) Suh‐Chin Wu   Biotechnology Journal

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

The COVID-19 vaccine development landscape

(2020) Tung Thanh Le et al.   NATURE REVIEWS DRUG DISCOVERY

Detection of Covid-19 in Children in Early January 2020 in Wuhan, China

(2020) Weiyong Liu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trials of BCG vaccine will test for covid-19 protection

(2020) Graham Lawton   NEW SCIENTIST

Vaccine designers take first shots at COVID-19

(2020) Jon Cohen   SCIENCE

Possible method for the production of a Covid-19 vaccine

(2020) Aung Myint et al.   VETERINARY RECORD

Developing a vaccine for covid-19

(2020) Sarah Caddy   BMJ-British Medical Journal

Covid-19: What do we know so far about a vaccine?

(2020) Elisabeth Mahase   BMJ-British Medical Journal

The COVID-19 pandemic and the use of MS disease-modifying therapies

(2020) Gavin Giovannoni et al.   Multiple Sclerosis and Related Disorders

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

(2020) Tao Guo et al.   JAMA Cardiology

Potential Effects of Coronaviruses on the Cardiovascular System

(2020) Mohammad Madjid et al.   JAMA Cardiology

Ongoing Clinical Trials for the Management of the COVID-19 Pandemic

(2020) Mark P. Lythgoe et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target

(2019) Shuofeng Yuan et al.   Nature Communications

Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases

(2019) Bisera Stepanovska et al.   PHARMACOLOGICAL RESEARCH

Angiopoietin-like proteins in multiple sclerosis

(2019) Rabeah Al-Temaimi et al.   JOURNAL OF NEUROIMMUNOLOGY

The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state

(2019) Leanne Hodson et al.   Nature Reviews Endocrinology

Lipidomic Profiling Reveals Significant Perturbations of Intracellular Lipid Homeostasis in Enterovirus-Infected Cells

(2019) Bingpeng Yan et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

(2019) Andreane Cartier et al.   SCIENCE

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

(2019) Gustavo Luna et al.   JAMA Neurology

Immune modulatory effects of statins

(2018) Robert Zeiser   IMMUNOLOGY

Host lipidome analysis during rhinovirus replication in human bronchial epithelial cells identifies potential therapeutic targets

(2018) An Nguyen et al.   JOURNAL OF LIPID RESEARCH

Sphingolipid signaling in renal fibrosis

(2018) Andrea Huwiler et al.   MATRIX BIOLOGY

The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives

(2018) Andrea Huwiler et al.   PHARMACOLOGY & THERAPEUTICS

Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication

(2018) Guido A. Gualdoni et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inhibition of cytosolic phospholipase A2α impairs an early step of coronavirus replication in cell culture

(2017) Christin Müller et al.   JOURNAL OF VIROLOGY

Sphingolipids and their metabolism in physiology and disease

(2017) Yusuf A. Hannun et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection

(2017) Qi Wu et al.   Scientific Reports

To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling

(2016) Wee Siong Chew et al.   PHARMACOLOGICAL RESEARCH

Building Viral Replication Organelles: Close Encounters of the Membrane Types

(2016) Peter D. Nagy et al.   PLoS Pathogens

Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease

(2015) Jasper F. W. Chan et al.   CLINICAL MICROBIOLOGY REVIEWS

Critical role of phospholipase A2group IID in age-related susceptibility to severe acute respiratory syndrome–CoV infection

(2015) Rahul Vijay et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Identification of Host Cell Factors Associated with Astrovirus Replication in Caco-2 Cells

(2015) Andrea Murillo et al.   JOURNAL OF VIROLOGY

Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis

(2015) L. Kappos et al.   NEUROLOGY

RNA virus replication depends on enrichment of phosphatidylethanolamine at replication sites in subcellular membranes

(2015) Kai Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis

(2015) Jie Zhou et al.   Virology Journal

MYC-induced reprogramming of glutamine catabolism supports optimal virus replication

(2015) Minh Thai et al.   Nature Communications

Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

(2014) Adriaan H. de Wilde et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Adenovirus E4ORF1-Induced MYC Activation Promotes Host Cell Anabolic Glucose Metabolism and Virus Replication

(2014) Minh Thai et al.   Cell Metabolism

ChREBP, a glucose-responsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovirus-infected cells

(2014) Yongjun Yu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking

(2013) Julie Blaising et al.   ANTIVIRAL RESEARCH

Targeting the Sphingosine Kinase/Sphingosine 1-Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases

(2013) Stephanie Schwalm et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Effect of Statin Therapy on Mortality in Patients With Ventilator-Associated Pneumonia

(2013) Laurent Papazian   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

(2013) V. Stalin Raj et al.   NATURE

A Mechanistic Paradigm for Broad-Spectrum Antivirals that Target Virus-Cell Fusion

(2013) Frederic Vigant et al.   PLoS Pathogens

Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: Open-label, randomized study*

(2011) Demosthenes Makris et al.   CRITICAL CARE MEDICINE

Methyl-β-Cyclodextrins Preferentially Remove Cholesterol from the Liquid Disordered Phase in Giant Unilamellar Vesicles

(2011) Susana A. Sanchez et al.   JOURNAL OF MEMBRANE BIOLOGY

Multifaceted roles for lipids in viral infection

(2011) Nicholas S. Heaton et al.   TRENDS IN MICROBIOLOGY

Role of Lipids in Virus Replication

(2011) M. Lorizate et al.   Cold Spring Harbor Perspectives in Biology

Regulation of Cholesterol and Fatty Acid Synthesis

(2011) J. Ye et al.   Cold Spring Harbor Perspectives in Biology

Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication

(2010) Nai-Yun Hsu et al.   CELL

A broad-spectrum antiviral targeting entry of enveloped viruses

(2010) M. C. Wolf et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glycosphingolipids as Receptors for Non-Enveloped Viruses

(2010) Stefan Taube et al.   Viruses-Basel

A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes

(2010) Jason A. Wojcechowskyj et al.   Viruses-Basel

Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics

(2010) Deborah L. Diamond et al.   PLoS Pathogens

Statins for the Prevention and Treatment of Infections

(2009) Imad M. Tleyjeh   ARCHIVES OF INTERNAL MEDICINE

Virus entry by macropinocytosis

(2009) Jason Mercer et al.   NATURE CELL BIOLOGY

Lipids as targets for novel anti-inflammatory therapies

(2009) Andrea Huwiler et al.   PHARMACOLOGY & THERAPEUTICS

Minimising Influenza Disease with Fibrates

(2008) L.M. Alleva et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum

(2008) Kèvin Knoops et al.   PLOS BIOLOGY